Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
What's new
Get the latest updates from What's new directly as they happen.
Follow now 334 followers
Latest posts
Last updated 5 minutes ago
Orphan designation: serdexmethylphenidate Treatment of idiopathic hypersomnia, 24/05/2024 Withdrawn
10 minutes ago
Orphan designation: serdexmethylphenidate Treatment of idiopathic hypersomnia, 24/05/2024 Withdrawn
Orphan designation: human MHC non-restricted cytotoxic T-cell line Treatment of ovarian cancer, 30/11/2009 Withdrawn
31 minutes ago
Orphan designation: human MHC non-restricted cytotoxic T-cell line Treatment of ovarian cancer...
Guidance and template for industry on implementing Shortage Prevention Plans (SPP)
1 day ago
Guidance and template for industry on implementing Shortage Prevention Plans (SPP)
Human medicines European public assessment report (EPAR): Rivastigmine 1 A Pharma, rivastigmine, Date of authorisation: 11/12/2009, Revision: 21, Status: Authorised
about 24 hours ago
Human medicines European public assessment report (EPAR): Rivastigmine 1 A Pharma, rivastigmine...
Timetable: Post-authorisation measures (PAMs) assessed by PRAC - ATMP
about 23 hours ago
Timetable: Post-authorisation measures (PAMs) assessed by PRAC - ATMP
Timetable: Post-authorisation measure (PAM) assessed by PRAC
about 23 hours ago
Timetable: Post-authorisation measure (PAM) assessed by PRAC
Human medicines European public assessment report (EPAR): Ocrevus, ocrelizumab, Date of authorisation: 08/01/2018, Revision: 27, Status: Authorised
about 23 hours ago
Human medicines European public assessment report (EPAR): Ocrevus, ocrelizumab, Date of authorisation...
Human medicines European public assessment report (EPAR): Epivir, lamivudine, Date of authorisation: 08/08/1996, Revision: 51, Status: Authorised
about 23 hours ago
Human medicines European public assessment report (EPAR): Epivir, lamivudine, Date of authorisation...
Human medicines European public assessment report (EPAR): Instanyl, fentanyl, Date of authorisation: 20/07/2009, Revision: 41, Status: Authorised
about 22 hours ago
Human medicines European public assessment report (EPAR): Instanyl, fentanyl, Date of authorisation...
Human medicines European public assessment report (EPAR): Epidyolex, cannabidiol, Date of authorisation: 19/09/2019, Revision: 23, Status: Authorised
about 22 hours ago
Human medicines European public assessment report (EPAR): Epidyolex, cannabidiol, Date of authorisation...
Orphan designation: florbetaben (18F) Diagnosis of AL amyloidosis, 22/04/2020 Positive
about 3 hours ago
Orphan designation: florbetaben (18F) Diagnosis of AL amyloidosis, 22/04/2020 Positive